ENVB
Enveric Biosciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Other
- Website enveric.com
- Employees(FY) 25
- ISIN US29405E2081
Performance
-8.7%
1W
-7.79%
1M
+1.08%
3M
-41.67%
6M
-35.38%
YTD
-44.74%
1Y
Profile
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead program is EB-373, an active metabolite of psilocybin, which is in Phase 1 clinical trials for the treatment of anxiety disorders; EVM-301 for treating mental health; and EV104 CBD + Celecoxib conjugate for treating osteoarthritis. The company also developing cannabinoid-infused topical product for the treatment of radiodermatitis; and cannabinoid and COX-2 inhibitor conjugation that is in pre-clinical stage for the treatment of OA/acute pain. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Technical Analysis of ENVB 2024-05-10
Overview:
In analyzing the technical indicators for ENVB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming trading days.
Trend An...
Recent News & Updates
- 2024-05-14 18:00
- 2024-05-13 20:00
- 2024-05-07 19:00
- 2024-05-02 05:50
- 2024-04-12 00:00
- 2024-03-31 22:53
- 2024-03-25 19:00
- 2024-03-18 19:00
- 2024-03-11 19:00
- 2024-02-29 01:04
Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?(Investorplace)
- 2024-02-28 18:00
- 2024-02-25 19:00
- 2024-02-22 19:00
- 2024-02-20 19:00
- 2024-01-02 19:00
- 2023-12-28 19:52
- 2023-12-27 19:00
- 2023-12-26 19:00
- 2023-12-19 19:00
- 2023-12-04 19:00
- 2023-11-28 19:00
- 2023-11-26 19:00
- 2023-11-23 19:00
- 2023-11-13 03:01
- 2023-10-30 20:00
- 2023-10-19 20:00
- 2023-10-17 20:00
- 2023-10-10 20:00
- 2023-10-02 20:00
- 2023-09-26 20:00
Page 1 of 4
previousnext